Doxycycline :: therapeutic use
Latest Paper:
Slotervaartziekenhuis, afd. Interne Geneeskunde, Amsterdam, The Netherlands. maarten.limper@slz.nl
A 38-year-old man presented at the first-aid department complaining of fever, general malaise and a painful left groin. The complaints had started shortly after an active holiday in Finland. Physical examination showed enlarged left sided inguinal lymph nodes and a marked eschar on the left lower leg. In terms of differential diagnosis a Rickettsia or a tularemia infection were considered. The pathogen for tularemia, Francisella tularensis subspecies holarctica, was isolated in wound discharge from the patient. Serology also indicated infection with F. tularensis. The patient was treated at home with oral doxycycline and recovered fully in a few days. In patients presenting with an eschar, rickettsiosis is often the first and only disease that is considered. This case report clearly emphasizes that a differential diagnosis of an eschar can be made and that this includes tularemia.
Most cited papers:
The effects of broad-spectrum antibiotic and placebo therapy in patients with chronic obstructive pulmonary disease in exacerbation were compared in a randomized, double-blinded, crossover trial. Exacerbations were defined in terms of increased dyspnea, sputum production, and sputum purulence. Exacerbations were followed at 3-day intervals by home visits, and those that resolved in 21 days were designated treatment successes. Treatment failures included exacerbations in which symptoms did not resolve but no intervention was necessary, and those in which the patient's condition deteriorated so that intervention was necessary. Over 3.5 years in 173 patients, 362 exacerbations were treated, 180 with placebo and 182 with antibiotic. The success rate with placebo was 55% and with antibiotic 68%. The rate of failure with deterioration was 19% with placebo and 10% with antibiotic. There was a significant benefit associated with antibiotic. Peak flow recovered more rapidly with antibiotic treatment than with placebo. Side effects were uncommon and did not differ between antibiotic and placebo.
Mesh-terms: Aged; Amoxicillin :: therapeutic use; Anti-Bacterial Agents :: therapeutic use; Double-Blind Method; Doxycycline :: therapeutic use; Drug Combinations :: therapeutic use; Dyspnea :: drug therapy; Female; Human; Lung Diseases, Obstructive :: complications; Lung Diseases, Obstructive :: drug therapy; Male; Middle Aged; Random Allocation; Respiratory Sounds :: physiopathology; Sputum :: drug effects; Sulfamethoxazole :: therapeutic use; Support, Non-U.S. Gov't; Trimethoprim :: therapeutic use; Trimethoprim-Sulfamethoxazole Combination;
Department of Oral Biology and Pathology, School of Dental Medicine, SUNY at Stony Brook, USA.
A seminal experiment involving a germ-free rat model of connective tissue breakdown (followed soon thereafter by a series of in vitro studies) identified an unexpected non-antimicrobial property of tetracyclines (TCs). This ability of TCs to inhibit matrix metalloproteinases (MMPs) such as collagenase was found to reflect multiple direct and indirect mechanisms of action, and to be therapeutically useful in a variety of dental (e.g., adult periodontitis) and medical (e.g., arthritis, osteoporosis, cancer) diseases. The site on the TC molecule responsible for its MMP-inhibitory activity was identified which led to the development of a series of chemically modified non-antimicrobial analogs, called CMTs, which also have therapeutic potential but do not appear to induce antibiotic side-effects. Longitudinal double-blind studies on humans with adult periodontitis have demonstrated that a sub-antimicrobial dose of doxycycline (previously reported to suppress collagenase activity in the periodontal pocket) is safe and effective and has recently been approved by the FDA as an adjunct to scaling and root planing.
Mesh-terms: Animals; Anti-Bacterial Agents :: pharmacology; Anti-Bacterial Agents :: therapeutic use; Collagenases :: antagonists & inhibitors; Connective Tissue :: drug effects; Connective Tissue :: enzymology; Doxycycline :: pharmacology; Doxycycline :: therapeutic use; Extracellular Matrix :: enzymology; Human; Metalloendopeptidases :: antagonists & inhibitors; Periodontal Diseases :: drug therapy; Periodontal Diseases :: enzymology; Protease Inhibitors :: pharmacology; Protease Inhibitors :: therapeutic use; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S. ; Tetracyclines :: chemistry; Tetracyclines :: pharmacology; Tetracyclines :: therapeutic use;
Department of Pediatric, SUNY Health Science Center, Brooklyn 11203.
Chlamydia pneumoniae is emerging as a significant cause of respiratory disease, including pneumonia and bronchitis, in humans. In this recently completed study of infection due to C. pneumoniae in patients presenting with pneumonia to SUNY Health Science Center at Brooklyn, we identified two individuals for whom cultures were positive on multiple occasions over a 1-year period. To determine the frequency of persistent respiratory infection with C. pneumoniae, follow-up specimens were obtained from nine individuals with culture-documented C. pneumoniae infection. Five of these individuals had persistent infection: four had a flulike illness characterized by pharyngitis, and one had bronchitis with prominent bronchospasm. All five individuals appeared to have acute C. pneumoniae infection as determined by results of serologic tests (titers of IgM antibody for all individuals were greater than or equal to 1:16). For three patients, cultures remained positive for 11 months despite therapy with 10- to 21-day courses of tetracycline or doxycycline. These observations suggest that persistent infection with C. pneumoniae may follow acute infection and may persist for many months. Infection with C. pneumoniae may be very difficult to eradicate with use of currently available antibiotics even if there is a clinical response to therapy.
Mesh-terms: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chlamydia Infections :: drug therapy; Chlamydia Infections :: microbiology; Chlamydophila pneumoniae :: isolation & purification; Chronic Disease; Doxycycline :: therapeutic use; Female; Follow-Up Studies; Human; Infant; Male; Middle Aged; Pneumonia :: drug therapy; Pneumonia :: microbiology; Tetracycline :: therapeutic use;
Amélie v Saint André,
Nathan M Blackwell,
Laurie R Hall,
Achim Hoerauf,
Norbert W Brattig,
Lars Volkmann,
Mark J Taylor,
Louise Ford,
Amy G Hise,
Jonathan H Lass,
Eugenia Diaconu,
Eric Pearlman
Parasitic filarial nematodes infect more than 200 million individuals worldwide, causing debilitating inflammatory diseases such as river blindness and lymphatic filariasis. Using a murine model for river blindness in which soluble extracts of filarial nematodes were injected into the corneal stroma, we demonstrated that the predominant inflammatory response in the cornea was due to species of endosymbiotic Wolbachia bacteria. In addition, the inflammatory response induced by these bacteria was dependent on expression of functional Toll-like receptor 4 (TLR4) on host cells.
Mesh-terms: Animals; Anti-Bacterial Agents :: pharmacology; Anti-Bacterial Agents :: therapeutic use; Brugia malayi :: physiology; Cornea :: immunology; Cornea :: metabolism; Cornea :: microbiology; Cornea :: parasitology; Dipetalonema :: physiology; Doxycycline :: pharmacology; Doxycycline :: therapeutic use; Drosophila Proteins; Eosinophils :: immunology; Human; Immunity, Natural; Keratitis :: immunology; Keratitis :: microbiology; Keratitis :: parasitology; Keratitis :: pathology; Membrane Glycoproteins :: genetics; Membrane Glycoproteins :: metabolism; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Microscopy, Confocal; Neutrophil Infiltration; Neutrophils :: immunology; Onchocerca volvulus :: immunology; Onchocerca volvulus :: microbiology; Onchocerca volvulus :: physiology; Onchocerciasis, Ocular :: immunology; Onchocerciasis, Ocular :: microbiology; Onchocerciasis, Ocular :: parasitology; Onchocerciasis, Ocular :: pathology; Receptors, Cell Surface :: genetics; Receptors, Cell Surface :: metabolism; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S. ; Symbiosis; Wolbachia :: immunology; Wolbachia :: pathogenicity; Wolbachia :: physiology;
Endosymbiotic bacteria living in plasmodia or worm parasites are required for the homoeostasis of their host and should be excellent targets for chemotherapy of certain parasitic diseases. We show that targeting of Wolbachia spp bacteria in Onchocerca volvulus filariae by doxycycline leads to sterility of adult worms to an extent not seen with drugs used against onchocerciasis, a leading cause of blindness in African countries.
Mesh-terms: Adolescent; Adult; Animals; Anti-Bacterial Agents :: pharmacology; Anti-Bacterial Agents :: therapeutic use; DNA, Bacterial :: analysis; DNA, Helminth :: analysis; Doxycycline :: pharmacology; Doxycycline :: therapeutic use; Female; Human; Male; Middle Aged; Onchocerca volvulus :: genetics; Onchocerca volvulus :: microbiology; Onchocerciasis :: drug therapy; Onchocerciasis :: microbiology; Polymerase Chain Reaction; Support, Non-U.S. Gov't; Symbiosis; Wolbachia :: drug effects; Wolbachia :: genetics; Wolbachia :: physiology;
Periodontal Disease Research Center, Department of Oral Biology, School of Dental Medicine, Buffalo, NY 14214, USA.
Periodontal disease is a common infection-induced inflammatory disease among individuals suffering from diabetes mellitus. The purpose of this study was to assess the effects of treatment of periodontal disease on the level of metabolic control of diabetes. A total of 113 Native Americans (81 females and 32 males) suffering from periodontal disease and non-insulin dependent diabetes mellitus (NIDDM) were randomized into 5 treatment groups. Periodontal treatment included ultrasonic scaling and curettage combined with one of the following antimicrobial regimens: 1) topical water and systemic doxycycline, 100 mg for 2 weeks; 2) topical .12% chlorhexidine (CHX) and systemic doxycycline, 100 mg for 2 weeks; 3) topical povidone-iodine and systemic doxycycline, 100 mg for 2 weeks; 4) topical .12% CHX and placebo; and 5) topical water and placebo (control group). Assessments were performed prior to and at 3 and 6 months after treatment and included probing depth (PD), clinical attachment level (CAL), detection of Porphyromonas gingivalis in subgingival plaque and determination of serum glucose and glycated hemoglobin (HbA1c). After treatment all study groups showed clinical and microbial improvement. The doxycycline-treated groups showed the greatest reduction in probing depth and subgingival Porphyromonas gingivalis compared to the control group. In addition, all 3 groups receiving systemic doxycycline showed, at 3 months, significant reductions (P < or = .04) in mean HbA1c reaching nearly 10% from the pretreatment value. Effective treatment of periodontal infection and reduction of periodontal inflammation is associated with a reduction in level of glycated hemoglobin. Control of periodontal infections should thus be an important part of the overall management of diabetes mellitus patients.
Mesh-terms: Adult; Aged; Anti-Bacterial Agents :: administration & dosage; Anti-Bacterial Agents :: therapeutic use; Anti-Infective Agents, Local :: administration & dosage; Anti-Infective Agents, Local :: therapeutic use; Arizona; Blood Glucose :: analysis; Chlorhexidine :: administration & dosage; Chlorhexidine :: therapeutic use; Comparative Study; Dental Plaque :: microbiology; Dental Scaling; Diabetes Mellitus, Type II :: blood; Diabetes Mellitus, Type II :: complications; Diabetes Mellitus, Type II :: metabolism; Doxycycline :: administration & dosage; Doxycycline :: therapeutic use; Female; Hemoglobin A, Glycosylated :: analysis; Human; Indians, North American; Iodophors :: administration & dosage; Iodophors :: therapeutic use; Male; Middle Aged; Mouthwashes; Periodontal Attachment Loss :: therapy; Periodontal Diseases :: complications; Periodontal Diseases :: microbiology; Periodontal Diseases :: therapy; Periodontal Pocket :: therapy; Periodontitis :: therapy; Placebos; Porphyromonas gingivalis :: drug effects; Povidone-Iodine :: administration & dosage; Povidone-Iodine :: therapeutic use; Subgingival Curettage; Support, U.S. Gov't, P.H.S. ; Ultrasonic Therapy;
Department of Medicine, Sappasitprasong Hospital, Ubon Ratchatani, Thailand.
From 1986 to 1991, 602 patients with melioidosis were seen in Sappasitprasong Hospital, Ubon Ratchatani, Thailand. The in-hospital mortality was 42%. Of 118 adult patients followed long-term, 27 (23%) had culture-proven relapses of melioidosis (3 relapsed twice), a relapse rate of 15%(95% confidence interval [CI], 11-22) per year. The median time from discharge to relapse was 21 weeks (range, 1-290). In 44% of patients, relapses included septicemia, and 27% died. Patients with severe disease (multiple foci of infection or septicemia) relapsed 4.7 times (95% CI, 1.6-14.1) more frequently than patients with localized melioidosis. Underlying disease was not a risk factor, but initial parenteral treatment with ceftazidime reduced the risk of relapse 2-fold (95% CI, 1.1-3.4). Relapses were 3.3 (95% CI, 1.4-9. ) times more frequent following short-course (< or = 8 weeks) oral coamoxiclav than after the oral combination regimen of chloramphenicol, doxycycline, and cotrimoxazole. Longer oral treatment with either reduced relapse 1.6-fold (95% CI, 1.2-1.9). The optimum choice and duration of antibiotic treatment to prevent relapse in melioidosis remain to be determined.
Mesh-terms: Adolescent; Adult; Amoxicillin :: therapeutic use; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents :: therapeutic use; Ceftazidime :: therapeutic use; Chloramphenicol :: therapeutic use; Clavulanic Acids :: therapeutic use; Comparative Study; Doxycycline :: therapeutic use; Drug Combinations; Female; Humans; Male; Melioidosis :: drug therapy; Melioidosis :: epidemiology; Melioidosis :: prevention & control; Middle Aged; Prospective Studies; Recurrence; Research Support, Non-U.S. Gov't; Risk Factors; Thailand :: epidemiology; Trimethoprim-Sulfamethoxazole Combination :: therapeutic use;
E T Takafuji,
J W Kirkpatrick,
R N Miller,
J J Karwacki,
P W Kelley,
M R Gray,
K M McNeill,
H L Timboe,
R E Kane,
J L Sanchez
Because leptospirosis has been an important cause of morbidity in U.S. soldiers training in the Republic of Panama, we conducted a randomized, double-blind, placebo-controlled field trial during the fall of 1982 to determine whether doxycycline was an effective chemoprophylactic agent against this infection. Doxycycline (200 mg) or placebo was administered orally on a weekly basis and at the completion of training to 940 volunteers from two U.S. Army units deployed in Panama for approximately three weeks of jungle training. Twenty cases of leptospirosis occurred in the placebo group (an attack rate of 4.2 per cent), as compared with only one case in the doxycycline group (attack rate, .2 per cent, P less than .001), yielding an efficacy of 95. per cent. This study demonstrated the value of doxycycline as a prophylactic drug against leptospirosis.
Mahmoud Torabinejad,
Abbas Ali Khademi,
Jalil Babagoli,
Yongbum Cho,
William Ben Johnson,
Krassimir Bozhilov,
Jay Kim,
Shahrokh Shabahang
Department of Endodontics, School of Dentistry, Loma Linda University, CA 92350, USA.
Various organic acids, ultrasonic instruments, and lasers have been used to remove the smear layer from the surface of instrumented root canals. The purpose of this study was to investigate the effect of a mixture of a tetracycline isomer, an acid, and a detergent (MTAD) as a final rinse on the surface of instrumented root canals. Forty-eight extracted maxillary and mandibular single-rooted human teeth were prepared by using a combination of passive step-back and rotary .04 taper nickel-titanium files. Sterile distilled water or 5.25% sodium hypochlorite was used as intracanal irrigant. The canals were then treated with 5 ml of one of the following solutions as a final rinse: sterile distilled water, 5.25% sodium hypochlorite, 17% EDTA, or a new solution, MTAD. The presence or absence of smear layer and the amount of erosion on the surface of the root canal walls at the coronal, middle, and apical portion of each canal were examined under a scanning electron microscope. The results show that MTAD is an effective solution for the removal of the smear layer and does not significantly change the structure of the dentinal tubules when canals are irrigated with sodium hypochlorite and followed with a final rinse of MTAD.
Mesh-terms: Chelating Agents :: chemistry; Chelating Agents :: therapeutic use; Citric Acid :: chemistry; Citric Acid :: therapeutic use; Comparative Study; Dental Alloys; Dental Pulp Cavity :: drug effects; Dental Pulp Cavity :: ultrastructure; Dentin :: drug effects; Dentin :: ultrastructure; Detergents :: chemistry; Detergents :: therapeutic use; Doxycycline :: chemistry; Doxycycline :: therapeutic use; Edetic Acid :: therapeutic use; Human; Microscopy, Electron, Scanning; Nickel; Polysorbates :: chemistry; Polysorbates :: therapeutic use; Root Canal Irrigants :: chemistry; Root Canal Irrigants :: therapeutic use; Root Canal Preparation :: instrumentation; Root Canal Preparation :: methods; Smear Layer; Sodium Hypochlorite :: therapeutic use; Statistics; Titanium; Water;
The antimicrobial agents amikacin and doxycycline, which are not conventionally considered for use in treatment of mycobacterial infections, inhibit growth of Mycobacterium fortuitum and Mycobacterium chelonei in vitro. Ten patients were treated with these drugs alone or in combination with some surgical procedure. Seven of the 10 patients were definitely cured by the therapy. Only one definite treatment failure occurred. Patients with infections due to M. fortuitum or M. chelonei that are susceptible in vitro to these drugs appear to benefit from chemotherapy.
Mesh-terms: Adult; Aged; Amikacin :: therapeutic use; Child, Preschool; Doxycycline :: therapeutic use; Female; Human; Kanamycin :: analogs & derivatives; Male; Middle Aged; Mycobacteria, Atypical :: drug effects; Mycobacterium Infections :: drug therapy; Mycobacterium Infections, Atypical :: drug therapy;
